Curaleaf Receives 5 Adult-Use License Approvals in Home State

Curaleaf Holdings (CSE: CURA) announced this afternoon that it has received approval for five adult use licenses in its home state of Massachusetts. Three of the licenses are final licenses, while two are considered provisional.

Of the five licenses granted in total, three are for the co-location of adult-use activities at currently licensed medical properties. One final license is for adult use sales at a currently medical-only dispensary in Oxford, Mass, while the two other final licenses are for adult-use cultivation and manufacturing at a currently operational facility in Webster, Mass.

The two provisional licenses are for retail locations in Provincetown, and Ware. Hanover appears to be the only medical dispensary which will not presently be licensed for adult-use products.

The final adult-use licenses will still require “Post final” inspections, as well as “Commence Operations” inspections, which are expected to occur in the coming months as per the company news release.

Curaleaf Holdings is currently trading at $10.17, up 3.67% on todays news that Cowen & Company had assigned the firm a price target of US$10.50 and a rating of outperform while initiating coverage on the company.


Information for this briefing was found via Curaleaf Holdings. The author has no securities or affiliations related to the discussed organizations. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

200 Grams of Gold And 21% Copper — That’s Not Normal | Matt Wilson – Sterling Metals

Silver at $100? This Time It Might Stay There. | David Morgan

Critical Minerals Are Rerating! | John Passalacqua – First Phosphate

Recommended

Steadright Enters MOU To Acquire Historic Goundafa Polymetallic Mine In Morocco

Military Seizes Power in Madagascar After President Flees

Related News

US Cannabis: Stifel Expects Growth To Decelerate In Q4 Earnings

On February 2nd, Stifel-GMP put out their fourth quarter 2021 earnings preview, calling it “The...

Wednesday, February 9, 2022, 04:33:00 PM

Curaleaf Holdings Reports Q4 2020 Revenues Of $230.3 Million, Net Loss Of $35.3 Million

Curaleaf Holdings (CSE: CURA) this evening reported total revenue of $230.3 million for the fourth...

Tuesday, March 9, 2021, 04:53:06 PM

Curaleaf: Canccord Slashes Price Target, Anticipates Headwinds For 2022

Earlier this month, Curaleaf Holdings, Inc. (CSE: CURA reported its fourth quarter and full year...

Monday, March 14, 2022, 09:27:00 AM

Curaleaf Sees Grassroots Shareholders Approve Transaction

Curaleaf Holdings (CSE: CURA) announced this morning that the shareholders of GR Companies, known as...

Friday, July 17, 2020, 01:20:06 PM

Curaleaf To Enter European Market With US$286 Million Acquisition

Curaleaf Holdings (CSE: CURA) this evening announced that it is making a move into European...

Tuesday, March 9, 2021, 04:15:39 PM